Spaictra, with its slogan "Qubits for care," is a groundbreaking startup focused on leveraging quantum-light and matter interaction to conduct chemical-free quantitative analysis in biological systems. Established in 2025 and headquartered in France, the company stands at the forefront of innovation in an emerging field that holds significant potential for disrupting traditional biological analysis methodologies.
In its latest funding round on 01 September 2025, Spaictra secured a €2.50M Seed investment, backed by prominent investors including OVNI Capital, Fund F by Female Founders, and Serena. This investment underscores the confidence these investors have in Spaictra's potential to capture significant market share in the biotech industry.
The company, although in its nascent stage, shows promise in redefining how biological systems are analyzed, which could eventually lead to major advancements in healthcare diagnostics and treatments. As Spaictra continues to develop its technologies, its growth trajectory will be one to watch closely in the coming years.